Health and Healthcare

Myriad Genetics : MYGN

All Myriad Genetics Articles

85 Articles

Paul Ausick | Jun 13, 2013 at 11:40 AM EDT

Supreme Court Justices Unanimous on Denying Patents for Human Genes

ThinkstockThe U.S. Supreme Court issued a unanimous 9-0 ruling today denying patent protection from human genes isolated from the body.…

Jon C. Ogg | Jun 7, 2013 at 8:10 AM EDT

Top Analyst Upgrades and Stocks to Buy: Brocade, Garmin, Myriad, Yum! Brands, More

Investors and traders are always searching for fresh research ideas that will lead to higher income or more profits. 24/7…

Jon C. Ogg | May 31, 2013 at 8:35 AM EDT

Top 12 Analyst Upgrades and Downgrades: Calpine, CME, CVS, Panera and More

Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits.…

Jon C. Ogg | May 14, 2013 at 1:58 PM EDT

Myriad Genetics, Angelina Jolie and Genomics in Focus

ThinkstockMyriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a…

Jon C. Ogg | May 13, 2013 at 8:00 AM EDT

Jefferies Stocks to Buy: Big Gains in Life Sciences and Diagnostics

ThinkstockIn theory, medical technology companies should be some of the market’s best-performing stocks. After all, it’s not really a cyclical…

Jon C. Ogg | May 8, 2013 at 8:30 AM EDT

Top Analyst Upgrades and Stocks to Buy: Home Depot, Lululemon, Myriad Genetics and More

Investors and traders are always on the lookout for fresh Wall Street research ideas of stocks to buy, value stocks…

Jon C. Ogg | Apr 15, 2013 at 1:21 PM EDT

Gene Patent Showdown for Myriad Comes to a Head

ThinkstockShould a company get to patent your genetic DNA? That is the question when it comes to Myriad Genetics Inc.…

Jon C. Ogg | Feb 11, 2013 at 8:35 AM EST

Bank of America Merrill Lynch Unveils Secular Growth Stock Buy List (BAC, PETM, HLF, MYGN, ACT, SAH, HEI, FEIC, LOPE)

The negative fourth-quarter gross domestic product (GDP) reading of -0.1% caught most Wall St. analysts and economists by surprise. This…

Jon C. Ogg | Oct 24, 2012 at 8:24 AM EDT

Top Analyst Upgrades and Downgrades (ACC, AAPL, BUD, CLS, CHKP, DLTR, DD, FB, MYGN, NOK, NSC, PVA, SEP, UTHR, WHR, KSU, HIG, ATVI, INTC, TWX)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research notes this Wednesday.…

Jon C. Ogg | Sep 25, 2012 at 8:05 AM EDT

Top Analyst Upgrades and Downgrades (ADP, BK, BWLD, EXPD, GPS, GE, GHDX, LIFE, MYGN, NKE, NOK, NTRS, P, PAYX, RHT, QCOR, SQNM, STT, TIVO, TOT, WAG)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday.…

Jon C. Ogg | May 21, 2012 at 8:35 AM EDT

Top Analyst Upgrades & Downgrades (AVP, BAC, BBY, BA, DCI, FB, GS, HLF, KIRK, MS, MYGN, NUAN, PBR, RHI, ROST, SWY, SPLK, TJX, ZBRA)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday. Avon…

Jon C. Ogg | May 18, 2012 at 7:47 AM EDT

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012…

Jon C. Ogg | May 11, 2012 at 8:46 AM EDT

Top Analyst Upgrades & Downgrades (ADTN, AAPL, ARNA, T, BEAM, BBBY, BBY, BWLD, CVX, HEK, JPM, MYGN, PRA, RSH, RXN, RIMM, SLF, TXRH, VZ)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Adtran Inc.…

Jon C. Ogg | Apr 20, 2012 at 8:31 AM EDT

Top Analyst Upgrades & Downgrades (ALTR, BAC, SAM, CHK, CRUS, ERJ, EZPW, GTE, XXIA, LL, MYGN, NXY, OKE, PAA, RVBD, SNDK, SYNM)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday.…

Jon C. Ogg | Aug 31, 2011 at 3:00 PM EDT

August’s New Massive Stock Buybacks… Over $30 Billion (LOW, CVS, CELG, COV, INTU, DISCA, HRS, LMT, RSG, LOW, ABC, MXIM, ANR, AVT, JAH, LUV, STJ, ECL, IPG, FRX, ACE, CLF, CTSH, KBR, NWL, VRX, AKAM, AOL, DLB, URBN, ACM, CHTR, MYGN, PFG, HSIC)

The pace of stock buyback announcements in the month of August was almost unbelievable. The pace was stronger at the…

1 2 3 4 5 6

Myriad Genetics : MYGN

All Myriad Genetics Articles

Supreme Court Justices Unanimous on Denying Patents for Human Genes

Top Analyst Upgrades and Stocks to Buy: Brocade, Garmin, Myriad, Yum! Brands, More

Top 12 Analyst Upgrades and Downgrades: Calpine, CME, CVS, Panera and More

Myriad Genetics, Angelina Jolie and Genomics in Focus

Jefferies Stocks to Buy: Big Gains in Life Sciences and Diagnostics

Top Analyst Upgrades and Stocks to Buy: Home Depot, Lululemon, Myriad Genetics and More

Gene Patent Showdown for Myriad Comes to a Head

Bank of America Merrill Lynch Unveils Secular Growth Stock Buy List (BAC, PETM, HLF, MYGN, ACT, SAH, HEI, FEIC, LOPE)

Top Analyst Upgrades and Downgrades (ACC, AAPL, BUD, CLS, CHKP, DLTR, DD, FB, MYGN, NOK, NSC, PVA, SEP, UTHR, WHR, KSU, HIG, ATVI, INTC, TWX)

Top Analyst Upgrades and Downgrades (ADP, BK, BWLD, EXPD, GPS, GE, GHDX, LIFE, MYGN, NKE, NOK, NTRS, P, PAYX, RHT, QCOR, SQNM, STT, TIVO, TOT, WAG)

Top Analyst Upgrades & Downgrades (AVP, BAC, BBY, BA, DCI, FB, GS, HLF, KIRK, MS, MYGN, NUAN, PBR, RHI, ROST, SWY, SPLK, TJX, ZBRA)

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Top Analyst Upgrades & Downgrades (ADTN, AAPL, ARNA, T, BEAM, BBBY, BBY, BWLD, CVX, HEK, JPM, MYGN, PRA, RSH, RXN, RIMM, SLF, TXRH, VZ)

Top Analyst Upgrades & Downgrades (ALTR, BAC, SAM, CHK, CRUS, ERJ, EZPW, GTE, XXIA, LL, MYGN, NXY, OKE, PAA, RVBD, SNDK, SYNM)

August’s New Massive Stock Buybacks… Over $30 Billion (LOW, CVS, CELG, COV, INTU, DISCA, HRS, LMT, RSG, LOW, ABC, MXIM, ANR, AVT, JAH, LUV, STJ, ECL, IPG, FRX, ACE, CLF, CTSH, KBR, NWL, VRX, AKAM, AOL, DLB, URBN, ACM, CHTR, MYGN, PFG, HSIC)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Myriad Genetics : MYGN

All Myriad Genetics Articles

Supreme Court Justices Unanimous on Denying Patents for Human Genes

Top Analyst Upgrades and Stocks to Buy: Brocade, Garmin, Myriad, Yum! Brands, More

Top 12 Analyst Upgrades and Downgrades: Calpine, CME, CVS, Panera and More

Myriad Genetics, Angelina Jolie and Genomics in Focus

Jefferies Stocks to Buy: Big Gains in Life Sciences and Diagnostics

Top Analyst Upgrades and Stocks to Buy: Home Depot, Lululemon, Myriad Genetics and More

Gene Patent Showdown for Myriad Comes to a Head

Bank of America Merrill Lynch Unveils Secular Growth Stock Buy List (BAC, PETM, HLF, MYGN, ACT, SAH, HEI, FEIC, LOPE)

Top Analyst Upgrades and Downgrades (ACC, AAPL, BUD, CLS, CHKP, DLTR, DD, FB, MYGN, NOK, NSC, PVA, SEP, UTHR, WHR, KSU, HIG, ATVI, INTC, TWX)

Top Analyst Upgrades and Downgrades (ADP, BK, BWLD, EXPD, GPS, GE, GHDX, LIFE, MYGN, NKE, NOK, NTRS, P, PAYX, RHT, QCOR, SQNM, STT, TIVO, TOT, WAG)

Top Analyst Upgrades & Downgrades (AVP, BAC, BBY, BA, DCI, FB, GS, HLF, KIRK, MS, MYGN, NUAN, PBR, RHI, ROST, SWY, SPLK, TJX, ZBRA)

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Top Analyst Upgrades & Downgrades (ADTN, AAPL, ARNA, T, BEAM, BBBY, BBY, BWLD, CVX, HEK, JPM, MYGN, PRA, RSH, RXN, RIMM, SLF, TXRH, VZ)

Top Analyst Upgrades & Downgrades (ALTR, BAC, SAM, CHK, CRUS, ERJ, EZPW, GTE, XXIA, LL, MYGN, NXY, OKE, PAA, RVBD, SNDK, SYNM)

August’s New Massive Stock Buybacks… Over $30 Billion (LOW, CVS, CELG, COV, INTU, DISCA, HRS, LMT, RSG, LOW, ABC, MXIM, ANR, AVT, JAH, LUV, STJ, ECL, IPG, FRX, ACE, CLF, CTSH, KBR, NWL, VRX, AKAM, AOL, DLB, URBN, ACM, CHTR, MYGN, PFG, HSIC)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026